Skip to main content

Table 1 Basic characteristics of the included patients before the treatment

From: Sequential non-invasive following short-term invasive mechanical ventilation in the treatment of tuberculosis with respiratory failure: a randomized controlled study

Parameters

Total (n = 44)

Sequential MV group (n = 24)

Conventional MV group (n = 20)

P value#

Age (yrs)

61.3 ± 14.5

63.9 ± 13.0

58.3 ± 15.9

0.209

Male (%)

28 (63.6)

17 (70.8)

11 (55.0)

0.277

BMI (kg/m2)

22.4 ± 2.5

22.8 ± 2.0

22.0 ± 3.0

0.307

Period of tuberculosis (yrs)

7.1 ± 8.9

8.4 ± 11.1

5.4 ± 5.2

0.243

Smoking (%)

28 (63.6)

15 (62.5)

13 (65.0)

0.864

Alcohol consuming (%)

23 (52.3)

12 (50.0)

11 (55.0)

0.741

COPD (%)

13 (29.5)

8 (33.3)

5 (25.0)

0.757

Pulmonary cavity (%)

14 (31.8)

7 (29.2)

7 (35.0)

0.679

Diabetes mellitus (%)

13 (29.5)

7 (29.2)

6 (30.0)

0.952

Hypertension (%)

8 (18.2)

6 (25.0)

2 (10.0)

0.199

Bacterial infection (%)

26 (59.1)

14 (58.3)

12 (60.0)

0.911

Application of antibiotic (%)

26 (59.1)

14 (58.3)

12 (60.0)

0.911

APACHE II score

11.4 ± 2.6

12.0 ± 2.3

10.7 ± 2.8

0.109

Respiratory rate (/min)

36.3 ± 4.6

35.7 ± 5.1

37.2 ± 3.9

0.289

Heart rate (/min)

136.6 ± 11.6

134.2 ± 13.8

139.5 ± 7.7

0.134

Oxygenation index (mm Hg)

92.5 ± 38.0

92.0 ± 43.8

93.2 ± 30.8

0.920

A-aDO2 (mm Hg)

65.3 ± 26.8

63.0 ± 26.0

68.1 ± 28.3

0.544

PaCO2 (mm Hg)

68.7 ± 19.8

66.4 ± 18.2

71.5 ± 21.7

0.402

Blood pH

7.27 ± 0.09

7.30 ± 0.09

7.25 ± 0.09

0.087

WBC (× 109/L)

15.8 ± 5.0

16.4 ± 5.8

15.1 ± 3.7

0.389

Percentage of NEU (%)

87.9 ± 4.2

88.3 ± 5.1

87.4 ± 2.8

0.446

CRP (mg/mL)

157.6 ± 46.4

159.4 ± 48.3

155.4 ± 45.2

0.779

  1. #Inter-group difference was calculated between sequential MV group and conventional MV group
  2. MV mechanical ventilation, BMI body mass index, COPD chronic obstructive pulmonary disease, APACHE acute physiology and chronic health evaluation, A-aDO2 alveolo-arterial oxygen partial pressure difference, WBC white blood cell, NEU neutrophil, CRP C-reactive protein